The acquisition includes Heraeus Epurio’s production facility in Dayton, Ohio, along with technical and sales teams located across Asia. By absorbing this business, Brewer Science gains direct control over the synthesis and formulation of critical components, including photoacid generators, photoinitiators, monomers, and crosslinkers. These specialty chemicals are essential for advanced lithography, where even microscopic trace-metal impurities can render a chip defective.
Dr. Sri Kommu, co-CEO of Brewer Science, stated that the integration allows the company to maintain a unified approach from the chemistry lab to the production floor. This consolidation is designed to ensure supply chain integrity as the industry pushes toward more demanding technology nodes. The acquisition complements the company's recent infrastructure growth, including the 2025 opening of its Arizona Innovation Center in Chandler.

Comments (0)
No comments yet. Be the first!